Sana Biotechnology Inc
SANA
NASDAQ
Biotechnology
$3.55
USD
-0.12 (-3.27%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.10B
Volume 3.7M
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-211.82M
TTM
+16.0%
YoY
Operating Cash Flow
$-132.24M
TTM
+26.8%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 10.3 | 10.3 | 12.2 | 11.5 | 10.8 |
Other Operating Expenses | 44.6 | 0.0 | 29.4 | 0.0 | 0.0 |
Total Operating Expenses | 95.0 | 43.5 | 61.2 | 48.6 | 65.4 |
Operating Income | -95.0 | -43.5 | -61.2 | -48.6 | -65.4 |
EBITDA | -47.5 | -40.3 | -58.1 | -46.2 | -63.2 |
Other Income / Expense | 0.6 | 0.4 | 1.1 | 0.5 | 0.7 |
Total Other Income / Expense | 1.2 | 1.4 | 2.4 | 1.4 | 1.8 |
Income Before Income Taxes | -93.8 | -42.2 | -58.8 | -47.2 | -63.6 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -93.8 | -42.2 | -58.8 | -47.2 | -63.6 |
Consolidated Net Income / Loss | -93.8 | -42.2 | -58.8 | -47.2 | -63.6 |
Net Income Attributable to Common Shareholders | -93.8 | -42.2 | -58.8 | -47.2 | -63.6 |
Basic EPS | -$0.39 | -$0.16 | -$0.21 | -$0.17 | -$0.22 |
Diluted EPS | -$0.39 | -$0.16 | -$0.21 | -$0.17 | -$0.22 |
Basic Shares Outstanding | 238.4M | 260.5M | 276.5M | 276.9M | 295.7M |
Diluted Shares Outstanding | 238.4M | 260.5M | 276.5M | 276.9M | 295.7M |